Background and objectives Atypical antipsychotics have been related with hyperglycaemia,
diabetes mellitus, weight gain and lipid alterations in some patients. This study analyzed …

Patients receiving treatment with atypical antipsychotics commonly experience weight gain,
which can cause considerable distress and can have deleterious effects on cardiovascular …

Anti-psychotic drugs, particularly the second generation, oratypical'agents, have been
implicated in the development of metabolic dysfunction such as diabetes mellitus. There is a …

The atypical antipsychotic clozapine has been reported to be associated with metabolic
adverse effects, including type-2 diabetes mellitus. We present two cases of diabetes …

Rationale With the antipsychotic drugs available today, especially with some of the newer,
atypical antipsychotics, metabolic side effects, such as weight gain, diabetes mellitus and …

Metabolic disorders, especially diabetes mellitus, occur more often in patients diagnosed
with psychiatric diseases than in the general population. The suggested reasons include …

Background: Recent studies have suggested that patients receiving atypical antipsychotic
drugs are at increased risk for developing diabetes mellitus. The purpose of this study is to …

Type 2 diabetes mellitus is a common disease, with a prevalence rate that is increasing
globally (King et al., 1998; Wild et al., 2004). It can remain undetected for many years …

Second Generation Antipsychotics and Risk of Diabetes Type II – Comparison between
Olanzapine and Risperidone Page 1 Coll. Antropol. 31 (2007) 4: 1105–1109 Original scientific …